Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.

Antimicrobial agents and chemotherapy - 1 Aug 2016

Chien Jung-Yien, Chien Shun-Tien, Chiu Wei-Yih, Yu Chong-Jen, Hsueh Po-Ren

Abstract excerpt

It is unclear whether the use of moxifloxacin (MFX), a newer synthetic fluoroquinolone, results in better outcomes in patients with ofloxacin (OFX)-resistant multidrug-resistant tuberculosis (MDR-TB). During the period from April 2006 to December 2013, a total of 2,511 patients with culture-confirmed tuberculosis (TB) were treated at a TB referral hospital in southern Taiwan. Of the 2,511 patients, 325 (12.9%)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to DNA Gyrase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Bacterial

Share to Fluoroquinolones

Share to Moxifloxacin

Share to Ofloxacin

Share to Taiwan

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 27216062
DOI: 10.1128/AAC.00425-16
PMCID: PMC4958188

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.PMID 27216062Read ↗

Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.Semantic proximity Read ↗

Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.Semantic proximity Read ↗

Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.Semantic proximity Read ↗

Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.Semantic proximity Read ↗

Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutations.Semantic proximity Read ↗

Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.Semantic proximity Read ↗

Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.Semantic proximity Read ↗

Stepwise Decrease in Moxifloxacin Susceptibility amongst Clinical Isolates of Multidrug-Resistant <i>Mycobacterium tuberculosis:</i> Correlation with Ofloxacin SusceptibilitySemantic proximity Read ↗

In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand.Semantic proximity Read ↗

Performance of Sequencing in Predicting Ofloxacin Resistance in Mycobacterium tuberculosis from Positive Bactec MGIT 960 Cultures.Semantic proximity Read ↗

Optimizing treatment of lepromatous form of leprosy using ofloxacin on top of standard multi-drug therapy in National Referral Hospital, Jakarta, IndonesiaSemantic proximity Read ↗

Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.